Explanation of "Composition of Capital Disclosure"
Mizuho Financial Group 【Consolidated】
As of September 30, 2020
(in million yen) | ||||
CC2: Reconciliation of regulatory capital to consolidated balance sheet | ||||
a | b | c | ||
Items | Consolidated balance sheet as | Reference to | Cross-reference to Appended | |
in published financial | ||||
Template CC1 | template | |||
statements | ||||
Assets | ||||
Cash and Due from Banks | 42,498,278 | |||
Call Loans and Bills Purchased | 243,267 | |||
Receivables under Resale Agreements | 12,666,551 | |||
Guarantee Deposits Paid under Securities Borrowing Transactions | 2,190,799 | |||
Other Debt Purchased | 2,676,047 | |||
Trading Assets | 14,564,434 | 6-a | ||
Money Held in Trust | 471,782 | |||
Securities | 43,314,534 | 2-b,6-b | ||
Loans and Bills Discounted | 86,501,633 | 6-c | ||
Foreign Exchange Assets | 1,936,636 | |||
Derivatives other than for Trading Assets | 1,439,293 | 6-d | ||
Other Assets | 4,413,001 | 6-e | ||
Tangible Fixed Assets | 1,101,614 | |||
Intangible Fixed Assets | 619,695 | 2-a | ||
Net Defined Benefit Asset | 924,167 | 3 | ||
Deferred Tax Assets | 23,368 | 4-a | ||
Customers' Liabilities for Acceptances and Guarantees | 5,938,130 | |||
Reserves for Possible Losses on Loans | (477,516) | |||
Reserve for Possible Losses on Investments | (0) | |||
Total Assets | 221,045,717 | |||
Liabilities | ||||
Deposits | 134,665,825 | |||
Negotiable Certificates of Deposit | 14,201,308 | |||
Call Money and Bills Sold | 1,903,686 | |||
Payables under Repurchase Agreements | 19,326,350 | |||
Guarantee Deposits Received under Securities Lending Transactions | 1,244,440 | |||
Commercial Paper | 921,282 | |||
Trading Liabilities | 8,487,342 | 6-f | ||
Borrowed Money | 7,275,166 | 8-a | ||
Foreign Exchange Liabilities | 402,476 | |||
Short-term Bonds | 331,447 | |||
Bonds and Notes | 9,639,781 | 8-b | ||
Due to Trust Accounts | 1,336,263 | |||
Derivatives other than for Trading Liabilities | 1,274,444 | 6-g | ||
Other Liabilities | 4,815,831 | |||
Reserve for Bonus Payments | 55,860 | |||
Reserve for Variable Compensation | 1,467 | |||
Net Defined Benefit Liability | 71,950 | |||
Reserve for Director and Corporate Auditor Retirement Benefits | 635 | |||
Reserve for Possible Losses on Sales of Loans | 1,142 | |||
Reserve for Contingencies | 4,180 | |||
Reserve for Reimbursement of Deposits | 25,205 | |||
Reserve for Reimbursement of Debentures | 17,663 | |||
Reserves under Special Laws | 2,506 | |||
Deferred Tax Liabilities | 133,564 | 4-b | ||
Deferred Tax Liabilities for Revaluation Reservefor Land | 62,555 | 4-c | ||
Acceptances and Guarantees | 5,938,130 | |||
Total Liabilities | 212,140,512 | |||
Net Assets | ||||
Common Stock | 2,256,767 | 1-a | ||
Capital Surplus | 1,135,948 | 1-b | ||
Retained Earnings | 4,260,606 | 1-c | ||
Treasury Stock | (7,025) | 1-d | ||
Total Shareholders' Equity | 7,646,297 | |||
Net Unrealized Gains (Losses) on Other Securities | 1,038,781 | |||
Deferred Gains or Losses on Hedges | 66,262 | 5 | ||
Revaluation Reserve for Land | 137,834 | |||
Foreign Currency Translation Adjustments | (170,773) | |||
Remeasurements of Defined Benefit Plans | 84,475 | |||
Total Accumulated Other Comprehensive Income | 1,156,580 | (a) | ||
Stock Acquisition Rights | 134 | |||
Non-Controlling Interests | 102,192 | 7 | ||
Total Net Assets | 8,905,205 | |||
Total Liabilities and Net Assets | 221,045,717 |
Note:
The regulatory scope of consolidation is the same as the accounting scope of consolidation.
(Appended template)
1. Shareholders' equity | ||||||
(1) Consolidated balance sheet | (in million yen) | |||||
Ref. No. | Consolidated balance sheet items | As of September 30, 2020 | Remarks | |||
1-a | Common Stock | 2,256,767 | ||||
1-b | Capital Surplus | 1,135,948 | ||||
1-c | Retained Earnings | 4,260,606 | ||||
1-d | Treasury Stock | (7,025) | ||||
Total Shareholders' Equity | 7,646,297 | |||||
(2) Composition of capital | ||||||
Basel III Template No. | Composition of capital disclosure | As of September 30, 2020 | Remarks | |||
Directly issued qualifying common share capital plus related stock | Shareholders' equity attributable to common shares (before | |||||
7,646,044 | adjusting national specific regulatory adjustments (earnings to be | |||||
surplus and retained earnings | ||||||
distributed)) | ||||||
1a | of which: capital and stock surplus | 3,392,716 | ||||
2 | of which: retained earnings | 4,260,352 | ||||
1c | of which: treasury stock (-) | 7,025 | ||||
of which: other than above | - | |||||
Directly issued qualifying Additional Tier 1 instruments plus | ||||||
31a | related stock surplus of which: classified as equity under applicable | - | ||||
accounting standards and the breakdown | ||||||
2. Intangible fixed assets | ||||||
(1) Consolidated balance sheet | ||||||
Ref. No. | Consolidated balance sheet items | As of September 30, 2020 | Remarks | |||
2-a | Intangible Fixed Assets | 619,695 | ||||
2-b | Securities | 43,314,534 | ||||
of which: share of goodwill of companies accounted for | 8,544 | Share of goodwill of companies accounted for using the equity | ||||
using the equity method | method | |||||
Income taxes related to above | (169,661) | |||||
(2) Composition of capital | ||||||
Basel III Template No. | Composition of capital disclosure | As of September 30, 2020 | Remarks | |||
8 | Goodwill (net of related tax liability, including those equivalent) | 66,672 | ||||
9 | Other intangibles other than goodwill and mortgage servicing rights | 391,905 | Software and other | |||
(net of related tax liability) | ||||||
Mortgage servicing rights (net of related tax liability) | - | |||||
20 | Amount exceeding the 10% threshold on specified items | - | ||||
24 | Amount exceeding the 15% threshold on specified items | - | ||||
74 | Mortgage servicing rights that are below the thresholds | - | ||||
for deduction (before risk weighting) | ||||||
3. Net Defined Benefit Asset | ||||||
(1) Consolidated balance sheet | ||||||
Ref. No. | Consolidated balance sheet items | As of September 30, 2020 | Remarks | |||
3 | Net Defined Benefit Asset | 924,167 | ||||
Income taxes related to above | (282,574) | |||||
(2) Composition of capital | ||||||
Basel III Template No. | Composition of capital disclosure | As of September 30, 2020 | Remarks | |||
15 | Net Defined Benefit Asset | 641,592 | ||||
4. Deferred tax assets | ||||||
(1) Consolidated balance sheet | ||||||
Ref. No. | Consolidated balance sheet items | As of September 30, 2020 | Remarks | |||
4-a | Deferred Tax Assets | 23,368 | ||||
4-b | Deferred Tax Liabilities | 133,564 | ||||
4-c | Deferred Tax Liabilities for Revaluation Reserve for Land | 62,555 | ||||
Tax effects on intangible fixed assets | 169,661 | |||||
Tax effects on net defined benefit asset | 282,574 |
(2) Composition of capital | ||||||
Basel III Template No. | Composition of capital disclosure | As of September 30, 2020 | Remarks | |||
Deferred tax assets that rely on future profitability excluding those | This item does not agree with the amount reported on the | |||||
10 | 13,869 | consolidated balance sheet due to offsetting of assets and | ||||
arising from temporary differences (net of related tax liability) | ||||||
liabilities. | ||||||
Deferred tax assets that rely on future profitability arising from | This item does not agree with the amount reported on the | |||||
280,095 | consolidated balance sheet due to offsetting of assets and | |||||
temporary differences (net of related tax liability) | ||||||
liabilities. | ||||||
21 | Amount exceeding the 10% threshold on specified items | - | ||||
25 | Amount exceeding the 15% threshold on specified items | - | ||||
Deferred tax assets arising from temporary differences | ||||||
75 | that are below the thresholds for deduction (before risk | 280,095 | ||||
weighting) | ||||||
5. Deferred gains or losses on derivatives under hedge accounting | ||||||
(1) Consolidated balance sheet | ||||||
Ref. No. | Consolidated balance sheet items | As of September 30, 2020 | Remarks | |||
5 | Deferred Gains or Losses on Hedges | 66,262 | ||||
(2) Composition of capital | ||||||
Basel III Template No. | Composition of capital disclosure | As of September 30, 2020 | Remarks | |||
Excluding those items whose valuation differences arising from | ||||||
11 | Deferred gains or losses on derivatives under hedge accounting | 123,464 | hedged items are recognized as "Total accumulated other | |||
comprehensive income" | ||||||
6. Items associated with investments in the capital of financial institutions | ||||||
(1) Consolidated balance sheet | ||||||
Ref. No. | Consolidated balance sheet items | As of September 30, 2020 | Remarks | |||
6-a | Trading Assets | 14,564,434 | Including trading account securities and derivatives for trading | |||
assets | ||||||
6-b | Securities | 43,314,534 | ||||
6-c | Loans and Bills Discounted | 86,501,633 | Including subordinated loans | |||
6-d | Derivatives other than for Trading Assets | 1,439,293 | ||||
6-e | Other Assets | 4,413,001 | Including money invested | |||
6-f | Trading Liabilities | 8,487,342 | Including trading account securities sold | |||
6-g | Derivatives other than for Trading Liabilities | 1,274,444 | ||||
(2) Composition of capital | ||||||
Basel III Template No. | Composition of capital disclosure | As of September 30, 2020 | Remarks | |||
Investments in own capital instruments | 6,378 | |||||
16 | Common Equity Tier 1 capital | 3,009 | ||||
37 | Additional Tier 1 capital | 2,200 | ||||
52 | Tier 2 capital | 1,169 | ||||
Reciprocal cross-holdings in the capital of banking, financial and | - | |||||
insurance entities | ||||||
17 | Common Equity Tier 1 capital | - | ||||
38 | Additional Tier 1 capital | - | ||||
53 | Tier 2 capital and other TLAC liabilities | - | ||||
Investments in the capital of banking, financial and insurance | ||||||
entities that are outside the scope of regulatory consolidation, net of | 437,746 | |||||
eligible short positions, where the bank does not own more than | ||||||
10% of the issued share capital (amount above 10% threshold) | ||||||
18 | Common Equity Tier 1 capital | - | ||||
39 | Additional Tier 1 capital | - | ||||
54 | Tier 2 capital and other TLAC liabilities | - | ||||
Investments in the other TLAC liabilities of banking, | ||||||
financial and insurance entities that are outside the scope | ||||||
54a | of regulatory consolidation, where the bank does not own | 712 | ||||
more than 10% of the issued common share capital of the | ||||||
entity: amount previously designated for the 5% threshold | ||||||
but that no longer meets the conditions | ||||||
Non-significant investments in the capital and other | ||||||
72 | TLAC liabilities of other financials that are below the | 437,033 | ||||
thresholds for deduction (before risk weighting) | ||||||
Significant investments in the capital of banking, financial and | ||||||
insurance entities that are outside the scope of regulatory | 318,150 | |||||
consolidation, net of eligible short positions | ||||||
19 | Amount exceeding the 10% threshold on specified items | - | ||||
23 | Amount exceeding the 15% threshold on specified items | - | ||||
40 | Additional Tier 1 capital | 44,403 | ||||
55 | Tier 2 capital and other TLAC liabilities | - | ||||
Significant investments in the common stock of financials | ||||||
73 | that are below the thresholds for deduction (before risk | 273,747 | ||||
weighting) | ||||||
7. Non-Controlling Interests | |||||
(1) Consolidated balance sheet | |||||
Ref. No. | Consolidated balance sheet items | As of September 30, 2020 | Remarks | ||
7 | Non-Controlling Interests | 102,192 | |||
(2) Composition of capital | |||||
Basel III Template No. | Composition of capital disclosure | As of September 30, 2020 | Remarks | ||
5 | Common share capital issued by subsidiaries and held by third | 8,002 | After reflecting amounts eligible for inclusion (Non-Controlling | ||
parties (amount allowed in group CET1) | Interest after adjustments) | ||||
30-31ab-32 | Qualifying Additional Tier 1 instruments plus related stock surplus | - | After reflecting amounts eligible for inclusion (Non-Controlling | ||
issued by special purpose vehicles and other equivalent entities | Interest after adjustments) | ||||
34-35 | Additional Tier 1 instruments issued by subsidiaries and held by | 19,478 | After reflecting amounts eligible for inclusion (Non-Controlling | ||
third parties (amount allowed in group AT1) | Interest after adjustments) | ||||
46 | Tier 2 instruments plus related stock surplus issued by special | 110,674 | After reflecting amounts eligible for inclusion (Non-Controlling | ||
purpose vehicles and other equivalent entities | Interest after adjustments) | ||||
48-49 | Tier 2 instruments issued by subsidiaries and held by third parties | 5,996 | After reflecting amounts eligible for inclusion (Non-Controlling | ||
(amount allowed in group Tier 2) | Interest after adjustments) | ||||
8. Other capital instruments | |||||
(1) Consolidated balance sheet | |||||
Ref. No. | Consolidated balance sheet items | As of September 30, 2020 | Remarks | ||
8-a | Borrowed Money | 7,275,166 | |||
8-b | Bonds and Notes | 9,639,781 | |||
Total | 16,914,948 | ||||
(2) Composition of capital | |||||
Basel III Template No. | Composition of capital disclosure | As of September 30, 2020 | Remarks | ||
Directly issued qualifying Additional Tier 1 instruments plus | |||||
32 | related stock surplus of which: classified as liabilities under | 2,042,000 | |||
applicable accounting standards | |||||
Directly issued qualifying Tier 2 instruments plus related stock | |||||
46 | surplus of which: classified as liabilities under applicable | 1,271,937 | |||
accounting standards | |||||
Attachments
- Original document
- Permalink
Disclaimer
Mizuho Financial Group Inc. published this content on 26 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 November 2020 08:14:09 UTC